This initiative funds multi-level and multi-domain intervention research aimed at reducing disparities in liver diseases and liver cancer among U.S. populations experiencing health disparities. The funding supports clinical trials optionally and follows simplified review criteria effective for applications due after January 25, 2025. Eligible applicants include a broad range of U.S.-based organizations including governments, nonprofits, educational institutions, and tribal entities.
Eligible applicants include a wide range of U.S.-based entities such as state and local governments, nonprofits, for-profit organizations, educational institutions, tribal governments, and others. Non-U.S. entities are not eligible to apply, though foreign components of U.S. organizations are allowe
